|
|
 |
 |
|
1. Highest resolution for protein isoform separation
|
 |
 |
|
1.a) Native separation of Protein Isoforms at pH extremes
|
 |
 |
|
Alkaline Ampholyte pH gradient for native IEF separation of Elastase Isoforms (pI 10.4); FFE conditions 2000V /19 mA, transit time 5 Minutes; chamber 500mm x 50mm x 0.15mm
|
|
|
 |
 |
|
M= protein marker S= crude sample 66-79= FFE Fractions
|
|
 |
 |
|
native IEF separation of Elastase Isoforms (pI 10.4) , visualized on a Serva IEF gel first dimension FFE-IEF pH 10.02 - 10.77, second dimension PAGIEF pH 3-11
|
 |
 |
|
Flat Ampholyte pH gradient for native IEF separation of Ovalbumin isoforms; FFE conditions 2500V /15 mA, transit time 7.5 Minutes; chamber 500mm x 50mm x 0.2mm
|
|
|
 |
 |
|
M= protein marker S= crude sample 40-52= FFE Fractions
|
|
 |
 |
|
native IEF separation of Ovalbumine Isoforms (pI 4.5) , visualized on a Serva IEF gel first dimension FFE-IEF pH 4.61 - 4.92, seciond dimension PAGIEF pH 3-11
|
 |
 |
|
1.b) Customized IEF separations for protein isoforms
|
 |
 |
|
Flat Ampholyte pH gradient of pH 4-6 for Isoform separations; FFE conditions: 2500V /12mA, transit time 6.5 Minutes; chamber 500mm x 50mm x 0.175mm
|
|
|
 |
 |
|
M/S= protein marker = used as sample
19- 53= FFE Fractions Am = Amyloglucosidase GO = Glucose Oxidase TI = Trypsin Inhibitor
|
|
 |
 |
|
Flat Ampholine pH gradient of pH 4-6 in the first dimension, second dimension PAGIEF 3-10
|
 |
 |
|
3. Separation of Isoforms (new protocol)
|
 |
 |
 |
 |
 |
 |
|
 |
|
|
|
example 1: isoform separation of ß-Lactoglobulin, isoforms at 5,15 (fraction 27-29) and 5,30 (fractions 41-43)
Benefits:
- no polymer added, this protocol is suitable for the purification of proteins and protein complexes prior to crystallization
- no commercial ampholytes used, this protocol gives first chance to analyze isoforms for clinical applications
|
|
|
|
 |
|
|
example 2:
isoform separation of Ovalbumin, isoforms between pH 4,5 - 4,7
Benefits:
- no polymer added, this protocol is suitable for the purification of proteins and protein complexes prior to crystallization
- no commercial ampholytes used, this protocol gives first chance to analyze isoforms for clinical applications
|
|
|
|
 |
|
|
|
example 3:
isoform separation of Amyloglucosidase, isoforms between pH 3,6 - 3,9
Benefits:
- no polymer added, this protocol is suitable for the purification of proteins and protein complexes prior to crystallization
- no commercial ampholytes used, this protocol gives first chance to analyze isoforms for clinical applications
|
|
 |
 |
|
2. Very high throughput for denaturing separations.
|
 |
 |
|
2.a) Quick denaturing prefractionation, low resolution
|
 |
 |
|
2.b) Quick denaturing prefractionation, medium resolution
|
|
|
 |
 |
|
M= protein marker S= crude sample 17-44= FFE Fractions
|
|
 |
 |
|
Fast separation of human thyroid cancer cells under denaturing conditions with higher resolution First dimension FFE-IEF, second dimension SDS-PAGE
|
 |
 |
|
2.c) Quick denaturing prefractionation, high resolution, buffers without polymer
|
|
|
 |
 |
|
M= protein marker S= crude sample 19-53= FFE Fractions
Unlimited concentraion possible after FFE separation
|
|
 |
 |
|
Fast separation of human thyroid cancer cells under denaturing conditions in Urea - Mannitol buffers with high resolution. First dimension FFE-IEF, second dimension SDS-PAGE, FFE conditions Urea-Mannitol buffer pH 3-10, transit time 3.5 Minutes.
|
 |
 |
|
3. New protocols for protein complex separation
|
 |
 |
|
3.a) Native IEF separation of protein complexes
|
|
|
 |
 |
|
M= protein marker S= crude sample 31-38= FFE Fractions
|
|
 |
 |
|
Native IEF separation of DPE2 protein complex, first dimension IEF FFE, second dimension SDS-PAGE
|
 |
 |
|
3.b) Native electrophoretic sieving for separation and purification of Protein Complexes
|
 |
|
 |
 |
 |
|
Electrophoretic sieving is a three step process to enrich the protein complex first in a separation buffer with low concentration of polymers then on a second step a high resolution separation is performed at a higher level of polymer. Finally the polymer is removed by ITP
|
|
|
First step, EM separation with low concentration of Polymer
|
|
|
|
 |
|
|
|
Second step, sieving with high concentration of Polymer
|
|
|
|
 |
|
|
|
Sieving complete workflow
|
|
 |
 |
|
I) Separation according to EM of Rubisco sample spiked with Amyloglucosidase and Trypsin inhibitor, first step low concenbtration of polymer, visualization SDS-PAGE
|
|
|
 |
 |
|
M= protein marker S= crude sample 25-56= FFE Fractions Am= Amyloglucosidase TI= Trypsin Inhibitor
|
|
 |
 |
|
II) Electrophoretic sieving of Rubisco sample spiked with Amyloglucosidase and Trypsin inhibitor, second step high concentration of polymer, visualization SDS-PAGE
|
 |
 |
|
III) Third step ITP enrichment of Rubisco to remove the polymer, visualization SDS-PAGE
|
|
|
 |
 |
|
M= protein marker S= crude sample 3 -40 = FFE Fractions
FFE conditions:
ITP to remove polymer
|
|
|
 |
 |
|
M= protein marker S= crude sample 47-77= FFE Fractions Am= Amyloglucosidase TI= Trypsin Inhibitor
FFE conditions:
sieving with high concentration of polymer
|
|
 |
 |
|
4. Customized ultra flat pH gradients with Ampholines for dedicated separation needs
|
 |
 |
|
5. Reproducibility and recovery
|
|
|
 |
 |
|
FFE conditions Glycerol-HPMC buffer pH 3-10 transit time 2 Minutes
|
|
 |
 |
|
Recovery rate
|
|